Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

129.59 +0.14 (+0.11%)
Streaming Delayed Price Updated: 10:44 AM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
49 50 Next >
3 Dividend-Paying Stocks to Buy in November and Hold Forever
Adding these stocks to your portfolio could lead to a lifetime of passive income. 
Via The Motley Fool
This Groundbreaking Device Just Keeps Winning for Abbott Labs
Its continuous glucose monitor has proven immensely effective in helping type 2 diabetes patients. 
Via The Motley Fool
Intuitive Surgical Stock is Both a Legacy and Next-Gen Play
It’s hard to believe that the da Vinci Surgical System developed by Intuitive Surgical (NASDAQ: ISRG) is turning 22 years old since its U.S. Food and Drug 
Via MarketBeat
Topics Economy
NYSE: ABT Investor Notice: Deadline on October 31, 2022 in Lawsuit Against Abbott Laboratories
San Diego, CA -- (SBWIRE) -- 10/31/2022 -- The Shareholders Foundation announced that a deadline is coming up on October 31, 2022 in the lawsuit filed for certain investors of Abbott Laboratories... 
Via SBWire
Is This Dividend King a Buy Near Its 52-Week Low?
Shares of this medical device and diagnostics stock have slumped in 2022. 
Via The Motley Fool
Stocks That Hit 52-Week Lows On Thursday
  Thursday saw 177 companies set new 52-week lows. 
Via Benzinga
Why Abbott Laboratories Stock Is Slumping Today
A potential drop-off in COVID-19 testing sales is weighing on the healthcare giant's shares today. 
Via The Motley Fool
Abbott Laboratories (ABT) Q3 2022 Earnings Call Transcript
ABT earnings call for the period ending September 30, 2022. 
Via The Motley Fool
Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Abbott Laboratories (ABT) Investors of Class Action and to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
ABT MONDAY DEADLINE NOTICE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Abbott Laboratories Investors to Secure Counsel Before Important October 31 Deadline in Securities Class Action - ABT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
ABBOTT LABORATORIES 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Abbott Laboratories - ABT
From Kahn Swick & Foti, LLC
Via Business Wire
Abbott Labs Reports Narrower-Than-Expected Quarterly Declines, And Shares Topple
The company's third-quarter results came in well ahead of expectations. 
Via Investor's Business Daily
Looking Into Abbott Laboratories's Recent Short Interest
Abbott Laboratories's (NYSE:ABT) short percent of float has fallen 16.33% since its last report. The company recently reported that it has 13.99 million shares sold short, which is 0.82% of all regular... 
Via Benzinga
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Latch, Azure, Abbott, and TuSimple and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022
Upgrades 
Via Benzinga
ABT FINAL DEADLINE: ROSEN, A TOP RANKED FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important October 31 Deadline in Securities Class Action - ABT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Is Abbott Laboratories Still a Good Dividend Stock to Buy?
Third-quarter results were less than encouraging on the surface, but what do they say about the road ahead for Abbott Laboratories? 
Via The Motley Fool
10 Dividend Kings That May Last Centuries
The following 10 Dividend Kings have increased their dividends for at least 50 consecutive years, and stand a good chance of increasing their dividends for another 50 years. 
Via Talk Markets
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Humanigen, Latch, Azure, and Abbott and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Amazon To $175? Plus JP Morgan Cuts Price Target On Meta Platforms
JP Morgan cut the price target on Amazon.com, Inc. (NASDAQ: AMZN) from $185 to $175. Amazon shares gained 2.2% to trade at $117.82 on Friday. 
Via Benzinga
Market Rallies, Hits Resistance As Treasury Yields Soar; Tesla, Netflix Are Big Movers: Weekly Review
Tesla hit lows on earnings while Netflix jumped. 
Via Investor's Business Daily
Want Passive Income? 3 Dividend Kings to Buy Right Now
These companies have what it takes to offer earnings growth over time. 
Via The Motley Fool
Bonds And Stocks Slide While Stock Earnings Split
The big headline of today was bonds including TLT and IEF extending their downward slide to fresh new lows of 2022. 
Via Talk Markets
Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade
When saving for retirement, it's important to think beyond near-term market troubles. 
Via The Motley Fool
Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday
Gainers Amprius Technologies, Inc. (NYSE: AMPX) jumped 77.3% to settle at $11.01 on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of... 
Via Benzinga
3 Stocks Set to Soar From 52-Week Lows
Calling a market bottom is nearly impossible and it isn't likely near but these stocks to buy should be shielded from further declines. 
Via InvestorPlace
ABT INVESTOR NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Abbott Laboratories Investors to Secure Counsel Before Important October 31 Deadline in Securities Class Action - ABT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Abbott Laboratories, M&T Bank And Some Other Big Stocks Moving Lower On Wednesday
U.S. stocks traded higher, with the Dow Jones gaining more than 100 points on Wednesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Session
Gainers SenesTech, Inc. (NASDAQ: SNES) shares jumped 102.6% to $0.47 after declining over 3% on Tuesday. SenesTech, during August, posted a Q2 loss of $0.21 per share. 
Via Benzinga
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
49 50 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.